Gouty arthritis: the diagnostic and therapeutic impact of dual-energy CT.
Tim Finkenstaedt, Andrei Manoliou, Martin Toniolo...
https://pubmed.ncbi.nlm.nih.gov/26847043/Actively Recruiting
Led by Semmelweis University · Updated on 2022-12-20
500
Participants Needed
3
Research Sites
N/A
Total Duration
Researchers are evaluating the role of photon-counting detector computed tomography PCD-CT in diagnosing chronic peripheral arthritides, including immune-mediated types like rheumatoid and psoriatic arthritis, as well as crystal deposition diseases such as gout. The study aims to compare PCD-CT with other imaging methods like MRI, conventional X-rays, and sonography to better detect arthritis-related changes. This research is observational and seeks to improve diagnostic accuracy using advanced imaging technology. Participants will undergo imaging with the novel PCD-CT device, which offers advantages like higher resolution, lower radiation, and better detection of bone erosions, soft tissues, and crystal deposits. Other imaging studies like MRI, X-rays, and ultrasound will also be performed for comparison. The study includes patients with rheumatoid arthritis, psoriatic arthritis, and crystal arthropathies, with assessments including physical exams and laboratory tests relevant to their diagnoses. Throughout the study, participants will be monitored for bone erosions, bone marrow edema, periarticular soft tissue involvement, and crystal deposit characterization over at least two years. Secondary outcomes include evaluating PCD-CTs performance in detecting active arthritis findings and structural damage for up to three years. Participants will have regular imaging and clinical assessments, with the goal of enhancing diagnostic tools for these arthritis conditions.
CONDITIONS
Novel Complex Radiodiagnostics of Peripherial Arthropathies
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Semmelweis University
Lead Sponsor
National Institute of Rheumatology and Physiotherapy, Hungary
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Baseline
Participants undergo imaging studies including photon-counting detector CT, MRI, and conventional radiography to assess peripheral arthropathies.
1 visit (in-person)
Duration - At least 2 to 3 years
Participants are monitored for changes in bone erosions, bone marrow edema, periarticular soft tissue involvement, and crystal deposit characterization.
Periodic visits for imaging and clinical assessment over 2 to 3 years
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Tim Finkenstaedt, Andrei Manoliou, Martin Toniolo...
https://pubmed.ncbi.nlm.nih.gov/26847043/Martin J Willemink, Mats Persson, Amir Pourmorteza...
https://pubmed.ncbi.nlm.nih.gov/30179101/Paul I Mallinson, Tyler M Coupal, Patrick D McLaughlin...
https://pubmed.ncbi.nlm.nih.gov/27870622/J E Adams, S Z Chen, P H Adams...
https://pubmed.ncbi.nlm.nih.gov/7096705/J Duryea, J T Dobbins, J A Lynch
https://pubmed.ncbi.nlm.nih.gov/12674232/Mikkel Østergaard, Bo Ejbjerg, Marcin Szkudlarek
https://pubmed.ncbi.nlm.nih.gov/15588973/Lisa K Stamp, Nigel G Anderson, Fabio Becce...
https://pubmed.ncbi.nlm.nih.gov/30714678/Takeshi Fukuda, Yoshinori Umezawa, Akihiko Asahina...
https://pubmed.ncbi.nlm.nih.gov/28674965/Thasia G Woodworth, Olga Morgacheva, Olga L Pimienta...
https://pubmed.ncbi.nlm.nih.gov/28398508/Semmelweis University
Lead Sponsor
National Institute of Rheumatology and Physiotherapy, Hungary
Collaborating Sponsor